David C Carroll

Address:

5715 Logan Ave S, Minneapolis, MN 55419

VIN:

JHLRE48597C118513

Make:

HONDA

Model:

CR-V

Year:

2007

US Patent:

7312981, Dec 25, 2007

Filed:

Nov 29, 2004

Appl. No.:

10/999168

Inventors:

David W. Carroll - Minneapolis MN, US

International Classification:

G06F 1/16
H04B 1/38

US Classification:

361683, 455566, 345169

Abstract:

A mobile personal computer including a case, a micro-display system, a speech recognition system, a microprocessor, and a power source. The case is sized for handling by a single, adult human hand. The micro-display system is maintained by the case and includes a screen viewable at a first face of the case. The speech recognition system is also maintained by the case and includes a microphone positioned at the first face of the case for collecting sound waves generated by a user's speech. The microprocessor is maintained within the case and is electronically connected to the micro-display system and the speech recognition system. Further, the microprocessor utilizes a personal computer operating system to perform computing operations. Finally, the power source is maintained within the case. With this configuration, the mobile personal computer is easily handled and operated with a single hand.

US Patent:

7585883, Sep 8, 2009

Filed:

Oct 31, 2005

Appl. No.:

11/264629

Inventors:

Ankush Argade - Foster City CA, US
David Carroll - San Francisco CA, US
Alexander B. Rossi - Reedsport OR, US

Assignee:

Rigel Pharmaceuticals, Inc. - South San Francisco CA

International Classification:

A61K 31/4418
A61K 31/4425

US Classification:

514349, 514347, 514348, 514350, 514351, 546294, 546296, 546297, 546298, 546300, 546301, 546302, 546303

Abstract:

The present invention is directed to substituted pyridines, methods for their preparation and methods for their use in the treatment and/or prevention of mast cell related conditions.

US Patent:

7884111, Feb 8, 2011

Filed:

Dec 7, 2006

Appl. No.:

11/567820

Inventors:

Ankush Argade - Foster City CA, US
Rajinder Singh - Belmont CA, US
Hui Li - Millbrae CA, US
David Carroll - San Francisco CA, US
Susan Catalano - Hayward CA, US

Assignee:

Rigel Pharmaceuticals, Inc. - South San Francisco CA

International Classification:

A61K 31/505
C07D 239/42
A01N 43/00

US Classification:

514275, 514256, 514183

Abstract:

The present invention provides 2,4-pyrimidinediamine compounds having antiproliferative activity, compositions comprising the compounds and methods of using the compounds to inhibit cellular proliferation and to treat proliferative diseases such as tumorigenic cancers.

US Patent:

7915273, Mar 29, 2011

Filed:

Feb 24, 2010

Appl. No.:

12/711534

Inventors:

Ankush Argade - Foster City CA, US
Arvinder Sran - Fremont CA, US
David Carroll - San Francisco CA, US
Jeffrey Clough - Redwood City CA, US
Kin Tso - San Francisco CA, US
Somasekhar Bhamidipati - Foster City CA, US
Sambaiah Thota - Woburn MA, US
Rajinder Singh - Belmont CA, US
Vanessa Taylor - San Francisco CA, US
Hui Li - Santa Clara CA, US
Esteban Masuda - Menlo Park CA, US

Assignee:

Rigel Pharmaceuticals, Inc. - South San Francisco CA

International Classification:

C07D 239/48
A61K 31/506

US Classification:

514275, 544323

Abstract:

The invention encompasses compounds having formula I and the compositions and methods using these compounds in the treatment of conditions in which modulation of the JAK pathway or inhibition of JAK kinases, particularly JAK3, are therapeutically useful.

US Patent:

7947698, May 24, 2011

Filed:

Mar 21, 2008

Appl. No.:

12/053382

Inventors:

Andy Atuegbu - Dublin CA, US
Vadim Markovtsov - San Mateo CA, US
Somasekhar Bhamidipati - Foster City CA, US
Rajinder Singh - Belmont CA, US
Vanessa Taylor - San Francisco CA, US
Sambaiah Thota - Fremont CA, US
Jeffrey Wayne Clough - Redwood City CA, US
David Carroll - San Francisco CA, US
Hui Li - Santa Clara CA, US
Robin Cooper - St. George Island FL, US

Assignee:

Rigel Pharmaceuticals, Inc. - South San Francisco CA

International Classification:

C07D 239/02
A01N 43/54

US Classification:

514275, 544317

Abstract:

The invention encompasses compounds having formula I and the compositions and methods using these compounds in the treatment of conditions in which modulation of the JAK pathway or inhibition of JAK kinases, particularly JAK3, are therapeutically useful.

US Patent:

8304422, Nov 6, 2012

Filed:

Dec 13, 2010

Appl. No.:

12/966839

Inventors:

Andy Atuegbu - Dublin CA, US
Vadim Markovtsov - San Mateo CA, US
Somasekhar Bhamidipati - Foster City CA, US
Rajinder Singh - Belmont CA, US
Vanessa Taylor - San Francisco CA, US
Sambaiah Thota - Fremont CA, US
Jeffrey Wayne Clough - Redwood City CA, US
David Carroll - San Francisco CA, US
Hui Li - Santa Clara CA, US
Robin Cooper - St. George Island FL, US

Assignee:

Rigel Pharmaceuticals, Inc. - South San Francisco CA

International Classification:

C07D 239/02
A01N 43/54

US Classification:

514275, 544317

Abstract:

The invention encompasses compounds having formula I and the compositions and methods using these compounds in the treatment of conditions in which modulation of the JAK pathway or inhibition of JAK kinases, particularly JAK3, are therapeutically useful.

US Patent:

20010030060, Oct 18, 2001

Filed:

Dec 22, 2000

Appl. No.:

09/745853

Inventors:

David Carroll - Northfield MN, US

International Classification:

H05K001/16

US Classification:

174/260000

Abstract:

A computing device unit includes a rigid-to-flexible protection mechanism for e.g. die-on-flex technologies. According to one example, a flexible electronic device includes an electronic component for generating or receiving signals, a substrate for supporting the electronic component, and structure for stiffening the substrate, the structure being disposed to provide the substrate with a first rigidity adjacent the electronic component and a second rigidity more distant from the electronic component, the first rigidity being greater than the second rigidity such that the electronic component is protected against excessive flexing.

US Patent:

20050113398, May 26, 2005

Filed:

Aug 6, 2004

Appl. No.:

10/913270

Inventors:

Ankush Argade - Foster City CA, US
Rajinder Singh - Belmont CA, US
Hui Li - Millbrae CA, US
David Carroll - San Francisco CA, US
Susan Catalano - Hayward CA, US

International Classification:

A61K031/505
A61K031/506

US Classification:

514275000

Abstract:

The present invention provides 2,4-pyrimidinediamine compounds having antiproliferative activity, compositions comprising the compounds and methods of using the compounds to inhibit cellular proliferation and to treat proliferative diseases such as tumorigenic cancers.